Sign In
Buy CVI
$33.33
+0.440 (+1.34%)
At Close: Aug 04, 2026
Exclusive: Peru mines set to restart; to hit 80% production in a month, industry official says
01:51pm, Thursday, 07'th May 2020
Peruvian miners are set to restart operations in coming days and ramp up to around 80% of normal production levels within a month, a senior official at the country's mining industry group told Reuters
CVR Energy Reports First Quarter 2020 Results and Announces Cash Dividend of 40 Cents
12:07am, Thursday, 07'th May 2020
SUGAR LAND, Texas, May 06, 2020 -- CVR Energy, Inc. (NYSE: CVI) today announced a net loss of $87 million, or 87 cents per diluted share, on net sales of $1.1 billion for the.
Exclusive: Peru mines set to restart; to hit 80% production in a month, industry official says
12:00am, Thursday, 07'th May 2020
Exclusive: Peru mines set to restart; to hit 80% production in a month, industry official says
Menarini bags blood cancer drug with $677M Stemline acquisition -
09:52pm, Tuesday, 05'th May 2020
Italian drugmaker Menarini has agreed to buy Stemline Therapeutics, bolting on an already-approved drug for a rare form
50 Kiplinger Stocks Billionaires Love And 29 Pay Dividends
07:01pm, Tuesday, 05'th May 2020
Kiplinger Investing publishes opportune stock and fund lists for investors online. This new list of 50 billionaire picks by Dan Burrows published 5/1/20. 29 of
ResTORbio's Reverse Merger With Adicet Should Unlock Substantial Value For Shareholders
07:54pm, Monday, 04'th May 2020
resTORbio announced a reverse merger with privately held Adicet Bio on April 29 that will result in resTORbio shareholders holding around a 25% stake in the new
Italy's Menarini Group to acquire Stemline Therapeutics in deal valued at up to $677 million
11:13am, Monday, 04'th May 2020
Privately held Menarini Group, an Italian drug and diagnostics company, said Monday it has agreed to acquire Stemline Therapeutics Inc. undefined in a deal...
Stemline Therapeutics To Go Private In $667M Transaction
12:00am, Monday, 04'th May 2020
The New York-based oncology-focused, commercial-stage biopharma Stemline Therapeutics Inc (NASDAQ: STML) ringed in merger Monday with a go-private deal valued at up to $667...
Carl Icahn, who's made a large bulk of his fortune in energy, has a new play in the industry
02:04pm, Saturday, 02'nd May 2020
Icahn's next energy bet could pay off through a takeover or a rebound in oil prices.
50 Top Stock Picks That Billionaires Love 2020
03:39pm, Friday, 01'st May 2020
They say on Wall Street that if you want to make a small fortune, start by investing a large one.The billionaires and big-time money managers below all have fortunes of various sizes, and studying whi
Who Can Beat Warren Buffett And Carl Icahn? The Average Fund Manager.
09:32pm, Thursday, 30'th Apr 2020
The average fund manager can take pride in this: Over the past 10 years, he or she has surpassed the returns of investing legends Warren Buffett and Carl Icahn.
How Does CVR Energy's (NYSE:CVI) P/E Compare To Its Industry, After Its Big Share Price Gain?
10:48am, Wednesday, 29'th Apr 2020
CVR Energy (NYSE:CVI) shareholders are no doubt pleased to see that the share price has bounced 37% in the last month...
What Is CVR Energy’s (NYSE:CVI) P/E Ratio After Its Share Price Rocketed?
10:43am, Wednesday, 29'th Apr 2020
CVR Energy (NYSE:CVI) shareholders are no doubt pleased to see that the share price has bounced 37% in the last month...
U.S. refinery earnings to detail troubled outlooks as fuel use slumps
08:52pm, Tuesday, 28'th Apr 2020
U.S. refiners are expected to report poor first-quarter results starting this week, but investors are more concerned about the outlook for coming months as various states ease movement restrictions de
UPDATE 1-U.S. refinery earnings to detail troubled outlooks as fuel use slumps
08:50pm, Tuesday, 28'th Apr 2020
U.S. refiners are expected to report poor first-quarter results starting this week, but investors are more concerned about the outlook for coming months as various states ease movement restrictions de
